We are live on
!
Find out more
SM
Sabby Management Portfolio holdings
AUM
$45.1M
1-Year Est. Return
74.25%
This Fund
S&P 500
This Quarter
Est. Return
-18.45%
1 Year Est. Return
-74.25%
3 Year Est. Return
-95.86%
5 Year Est. Return
-99.36%
10 Year Est. Return
-99.46%
AUM
$122M
AUM Growth
+$7.43M
(+6.5%)
Cap. Flow
+$13.4M
Cap. Flow
% of AUM
10.99%
Top 10 Holdings %
Top 10 Hldgs %
82.45%
Holding
116
New
28
Increased
22
Reduced
30
Closed
27
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BCLI
BRAINSTORM CELL THERAPUTC
BCLI
|
+$3.5M |
| 2 |
PBLA
Panbela Therapeutics, Inc. Common Stock
PBLA
|
+$2.24M |
| 3 |
Sidus Space
SIDU
|
+$1.75M |
| 4 |
BIOR
Biora Therapeutics, Inc. Common Stock
BIOR
|
+$1.7M |
| 5 |
GlucoTrack
GCTK
|
+$1.22M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
APCX
AppTech Payments
APCX
|
+$1.03M |
| 2 |
CN Energy Group
CNEY
|
+$799K |
| 3 |
ARDS
Aridis Pharmaceuticals Inc. Common Stock
ARDS
|
+$672K |
| 4 |
Dogness International Corp
DOGZ
|
+$543K |
| 5 |
Huadi International Group
HUDI
|
+$528K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.59% |
| 2 | Consumer Discretionary | 2% |
| 3 | Industrials | 1.44% |
| 4 | Financials | 1.38% |
| 5 | Communication Services | 1.12% |
Similar funds
CG
OC
ICCON
PCM
CAS
CM
MCMC
CTC
Sabby Management's Q2 2023 Portfolio in Review
As of Q2 2023, Sabby Management held 116 positions worth $122M, up 6.5% from $115M the previous quarter. Its ten largest holdings account for 82% of the portfolio.
Sabby Management deployed $13.4M of net new capital in Q2 2023, opening 28 new positions and adding to 22 existing holdings. Its largest new stake was BRAINSTORM CELL THERAPUTC: 84,525 shares worth $2.61M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 9.8% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was CN Energy Group, an estimated $799K trimmed.
- Sabby Management's largest Q2 2023 buy was BRAINSTORM CELL THERAPUTC: 84,525 shares worth $2.61M.
- Sabby Management added most to Panbela Therapeutics, Inc. Common Stock in Q2 2023, an estimated $2.24M increase.
- Sabby Management's biggest Q2 2023 reduction was CN Energy Group, cutting an estimated $799K.
- Sabby Management fully exited AppTech Payments in Q2 2023, selling an estimated $1.03M.
- Sabby Management's ten largest holdings make up 82% of its $122M portfolio in Q2 2023.
- Sabby Management opened 28 new positions and closed 27 in Q2 2023.
- Sabby Management's portfolio value rose 6.5% quarter-over-quarter to $122M.
Based on Sabby Management's 13F filing for Q2 2023, filed 14 Aug 2023.